Patent ID: 9689042
Date: 2017-06-27
CPC Classifications: A61K,C12Q,G01N

Claim:
1. A method, comprising: measuring an expression level of at least one cellular marker selected from the group consisting of: platelet-type phosphofructokinase (PFKP); glyceraldehyde-3-phosphate dehydrogenase (GAPDH); aldolase (ALDO); lactate dehydrogenase A (LDHA); glucose transporter 3 (GLUT3); and glutamine-fructose-6-phosphate transaminase (GFPT), in a cell suspected of having increased oncogenic signaling; and determining whether the measured expression level of said at least one cellular marker in said cell suspected of having increased oncogenic signaling is increased relative to the expression level of said at least one cellular marker in a reference cell.